Inhibition of MST3, a STE20-type kinase, alleviates metabolic dysfunction-related steatohepatitis in mice without influencing the development of hepatocellular carcinoma - Top-Institutions - MDSpire

Inhibition of MST3, a STE20-type kinase, alleviates metabolic dysfunction-related steatohepatitis in mice without influencing the development of hepatocellular carcinoma

  • By

  • Jingjing Zhang

  • Xiangdong Gongye

  • Lohitesh Kovooru

  • Emma Andersson

  • Bernice Asiedu

  • Manoj Amrutkar

  • Nadia Gul

  • Caitlyn Myers

  • Sheri Booten

  • Dan Emil Lind

  • Ying Xia

  • Antonio Molinaro

  • Anetta Härtlova

  • Per Lindahl

  • Sue Murray

  • Margit Mahlapuu

  • March 24, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Diego (UCSD) School of Medicine
    University of California, San Diego (UCSD) School of Medicine

    San Diego, CA

    Key Differentiators

    • Hepatology
    • Metabolic Liver Disease
    • Molecular Biology
  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hepatology
    • Liver Disease
    • Clinical Research
  • #3

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Hepatology
    • Metabolic Disease
    • Translational Medicine
  • #4

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Hepatology
    • Molecular Genetics
    • Metabolic Disease
  • #5

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Hepatology
    • Translational Research
    • Oncology

Original Source(s)

Related Content